Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
KNR Constructions
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Rising Compliance Costs And Tech Shifts Will Erode Margins
Key Takeaways Heightened regulatory pressures, limited technological advancement, and regional concentration expose the company to compliance, operational, and geographic risks impacting future revenue stability. Dependence on government contracts and growing competition, combined with rising input costs, threaten liquidity, earnings, and long-term margin sustainability.
View narrative
₹156.00
FV
33.9% overvalued
intrinsic discount
-2.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Serica Energy
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Aging North Sea Assets Will Limit Output But Spark Recovery
Key Takeaways Heavy reliance on North Sea assets and exposure to regulatory, maintenance, and decommissioning risks threaten production growth and long-term cash flow stability. Structural headwinds from energy transition and asset maturity could erode future demand and reserves, impacting the company's ability to sustain earnings and dividends.
View narrative
UK£1.89
FV
12.7% undervalued
intrinsic discount
4.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
NOCIL
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Chinese Dumping And EV Shifts Will Shrink Profitability
Key Takeaways Severe pricing pressure from Chinese competitors and the threat of ineffective antidumping measures could erode revenue, margins, and market share significantly. Shifting industry trends toward electric vehicles, sustainability, and alternative materials are likely to constrain demand, increase compliance costs, and threaten long-term profitability.
View narrative
₹172.00
FV
1.4% overvalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Bytes Technology Group
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Margin And Microsoft Risk Will Curb Gains Yet Spark Hope
Key Takeaways Shifts toward automation, cloud subscriptions, and direct vendor sales threaten the company's traditional reseller model and may pressure margins and revenue growth. Heavy dependence on key vendor partnerships and challenges scaling higher-margin services or expanding internationally could constrain future profitability and growth.
View narrative
UK£3.80
FV
2.6% undervalued
intrinsic discount
3.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
hipages Group Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Australia And NZ Platforms Will Face Labor Constraints Yet Adapt
Key Takeaways Tight labor supply and regulatory pressures may constrain growth, compress margins, and cap revenue expansion despite improvements in platform efficiency and customer engagement. Competition from global tech giants and reliance on traditional trade services expose hipages to market share risks and potential limits on its long-term addressable market.
View narrative
AU$1.35
FV
28.9% undervalued
intrinsic discount
11.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
UTIA
UTI Asset Management
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Digital Disruption And Regulatory Pressure Will Undermine Fee Structures
Key Takeaways Rising preference for passive and alternative assets, along with slow digital adoption, threatens UTI AMC's revenue growth and scalability. Regulatory pressures and disrupted distribution channels are expected to compress margins and diminish long-term profitability.
View narrative
₹1.03k
FV
28.6% overvalued
intrinsic discount
8.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Xplora Technologies
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Rising Smartphone Trends Will Shrink Niche Markets But Offer Resilience
Key Takeaways Rising smartphone adoption and intense hardware competition threaten long-term growth and could limit Xplora's ability to sustain revenues in its core wearable segments. Data privacy regulations and heavy reliance on niche offerings create operational risks that may constrain scalability and expose Xplora to earnings volatility.
View narrative
NOK 48.50
FV
1.0% overvalued
intrinsic discount
32.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Medicover
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising European Labor Costs And Regulatory Burdens Will Squeeze Margins
Key Takeaways Sustained cost pressures, workforce shortages, and integration issues threaten Medicover's margins and ability to achieve expected synergies from acquisitions. Heightened regulatory, technological, and macroeconomic risks may limit efficiency gains and expose Medicover to market share loss and volatile revenue growth.
View narrative
SEK 219.70
FV
22.0% overvalued
intrinsic discount
8.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Byrna Technologies
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulatory Risks Will Weigh On Prospects Yet Progress Will Emerge
Key Takeaways Expansion into retail and international channels supports growth, but regulatory and geopolitical risks may limit sustained revenue and margin gains. Product innovation and e-commerce initiatives boost revenue opportunities, yet consumer sensitivity and competing security technologies threaten long-term earnings stability.
View narrative
US$35.00
FV
39.6% undervalued
intrinsic discount
21.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies